Avimanyou Vatsa | Bioinformatics | Excellence in Research Award

Excellence in Research Award

Avimanyou Vatsa -Fairleigh Dickinson University, United States

Avimanyou Vatsa
Affiliation Fairleigh Dickinson University
Country United States
Scopus ID 55882075300
Documents 24
Citations 133
h-index 7
Subject Area Bioinformatics
Event Technology Scientists Awards
ORCID 0000-0001-6694-7967

Avimanyou Vatsa is a researcher affiliated with Fairleigh Dickinson University, United States, whose scholarly contributions encompass computational methods, biological image analysis, agricultural phenotyping, and data-driven modelling. His publications address interdisciplinary research challenges involving computational techniques and scientific data interpretation. His research record includes contributions to machine learning and image-based analysis, alongside emerging work in sequential and graph-based modelling. [1]

Abstract

This article presents the academic profile and research contributions of Avimanyou Vatsa, affiliated with Fairleigh Dickinson University, United States. His scholarly work covers computational research, biological image analysis, agricultural phenotyping, and machine learning. His publications demonstrate interdisciplinary engagement with scientific data processing, computational modelling, and emerging analytical methodologies. [1]

Keywords

Avimanyou Vatsa; Excellence in Research Award; Bioinformatics; Machine Learning; Computational Research; Graph Neural Networks; Agricultural Phenotyping; Biological Image Analysis; Image Processing; Sequential Models; Scientific Computing; Research Excellence.

Introduction

Avimanyou Vatsa is associated with interdisciplinary scientific research involving computational techniques and data-driven investigation. His academic publications address challenges in agricultural image analysis, biological phenotyping, and computational modelling. These research areas connect computer science with biological applications, supporting the development of analytical approaches for understanding complex scientific datasets. [1] [2]

Research Profile

Vatsa’s research profile reflects an interdisciplinary orientation spanning bioinformatics, computational methods, image processing, and machine learning. His publication record includes studies addressing agricultural phenotyping and computational prediction. According to the supplied Scopus profile information, his scholarly metrics comprise 24 documents, 133 citations, and an h-index of seven. [2] [3]

Research Contributions

His research contributions include computational approaches to extracting complex biological phenotypes and examining imaging challenges in field-crop research. His collaborative publication on stock forecasting further explores sequential learning and graph neural networks. These studies illustrate the application of computational intelligence to different scientific and analytical problems. [2]

Publications

Vatsa’s listed publications cover stock forecasting using sequential models and graph neural networks, imaging challenges in field-crop phenotyping, and extraction of complex lesion phenotypes in Zea mays. These works represent collaborative research across computational modelling, machine learning, image analysis, and agricultural applications, demonstrating the multidisciplinary scope of his scholarly publications. [2] [3]

Research Impact

The research record demonstrates engagement with scientific problems requiring computational analysis and interdisciplinary collaboration. Work on agricultural phenotyping contributes to discussions about extracting meaningful biological information from field images. Computational forecasting research explores relationships between sequential information and graph structures. The supplied Scopus metrics indicate measurable scholarly visibility and citation activity. [1] [2]

Award Suitability

The Excellence in Research Award recognizes scholarly activity, research contributions, and academic engagement across scientific disciplines. Vatsa’s documented publications, interdisciplinary research interests, and supplied citation indicators provide relevant evidence for consideration. His work connecting computational approaches with biological and analytical applications offers a basis for evaluating his research profile. [1]

Conclusion

Avimanyou Vatsa’s academic profile reflects interdisciplinary contributions involving computational research, machine learning, biological image analysis, and scientific modelling. His selected publications demonstrate engagement with agricultural and computational research challenges. His documented scholarly activity and research record provide a foundation for recognition through the Excellence in Research Award at the Technology Scientists Awards. [1] [2] [3]

References

  1. Joseph, O., Sukumar, P., Ulloa, R., Vatsa, A., & Casti, A. (2026). Stock forecasting using sequential models and GNN. Analytics, 5(4), Article 43.
    https://doi.org/10.3390/analytics5040043
  2. Kelly, D., Vatsa, A., Mayham, W., Ngô, L., Thompson, A., et al. (2016). An opinion on imaging challenges in phenotyping field crops. Machine Vision and Applications, 27, 681–694.
    https://doi.org/10.1007/s00138-015-0728-4
  3. Kelly, D., Vatsa, A., Mayham, W., et al. (2016). Extracting complex lesion phenotypes in Zea mays. Machine Vision and Applications, 27, 145–156.
    https://doi.org/10.1007/s00138-015-0718-6

Olfa Khalfallah | Bioinformatics | Data Science Award

Olfa Khalfallah – Data Science Award

Olfa Khalfallah · Institute of Molecular and Cellular Pharmacology · France

Olfa Khalfallah
Affiliation Institute of Molecular and Cellular Pharmacology
Country France
Scopus ID 8641392600
Documents 33
Citations 502
h-index 13
Subject Area Bioinformatics
Event Technology Scientists Awards
ORCID 0000-0002-9093-1591

Olfa Khalfallah is associated with the Institute of Molecular and Cellular Pharmacology in France. The supplied academic profile identifies bioinformatics as the subject area and reports 33 documents, 502 citations, and an h-index of 13. The provided publication records address inflammatory biomarkers, early-life health outcomes, and the statistical agreement of multiplex cytokine immunoassay platforms. [1] [2] [3]

Abstract

This article presents an academic profile of Olfa Khalfallah, affiliated with the Institute of Molecular and Cellular Pharmacology in France. The supplied publications examine cord-blood C-reactive protein and childhood attention-related symptoms, agreement between cytokine immunoassay platforms, and maternal body mass index in relation to inflammatory biomarkers at birth. These topics connect biological measurement, statistical analysis, and health research. [1] [2] [3]

Keywords

Bioinformatics; data science; molecular pharmacology; inflammatory biomarkers; C-reactive protein; cytokine immunoassays; intraclass correlation; Bland–Altman analysis; maternal body mass index; birth cohorts; Technology Scientists Awards.

Introduction

Bioinformatics and data science support the interpretation of biological measurements and the investigation of health-related questions. The supplied publications explore inflammatory biomarkers in early-life and maternal contexts, alongside statistical comparisons of multiplex cytokine assay platforms. These themes illustrate the importance of reliable measurement, appropriate analytical methods, and careful interpretation of biomedical data. [1] [2] [3]

Research Profile

Olfa Khalfallah is affiliated with the Institute of Molecular and Cellular Pharmacology in France. The supplied profile identifies bioinformatics as the subject area and lists 33 documents, 502 citations, and an h-index of 13. The provided publication titles indicate research involving inflammatory biomarkers, maternal and early-life health, and quantitative assessment of laboratory measurement agreement. [1] [2] [3]

Research Contributions

The supplied works address three complementary questions: associations between cord-blood C-reactive protein and childhood symptoms, absolute agreement across multiplex cytokine immunoassay platforms, and relationships between pre-pregnancy body mass index and inflammatory biomarkers at birth. Together, they highlight biomarker interpretation, measurement reliability, and the analysis of maternal and early-life health data. [1] [2] [3]

Publications

The three supplied records span epidemiological investigation, laboratory-method comparison, and maternal biomarker research. Their topics are relevant to biomedical data analysis because reliable conclusions depend on study design, measurement consistency, and careful interpretation of observed associations. Full author lists, publication dates, journal metadata, and DOI identifiers should be verified against the original publisher or PubMed records before finalizing formal APA citations. [1] [2] [3]

Research Impact

The supplied profile reports 502 citations and an h-index of 13, providing bibliometric indicators of research visibility. The listed studies address issues relevant to biomedical evidence, including biomarker associations and the reproducibility of measurements across analytical platforms. Such work may inform research interpretation, although its practical impact should be assessed using verified findings, study quality, and subsequent independent evidence. [1] [2]

Award Suitability

The supplied publication topics and bibliometric indicators provide a basis for considering Olfa Khalfallah for the Data Science Award at the Technology Scientists Awards. Research involving biomarker analysis, cohort data, and assay agreement aligns with quantitative approaches to biomedical questions. A complete assessment should verify authorship, individual contributions, publication details, methodological quality, and the accuracy of the reported metrics. [1] [2] [3]

Conclusion

Olfa Khalfallah’s supplied academic profile connects bioinformatics with biomedical research on inflammatory biomarkers, early-life health, and laboratory measurement agreement. The three listed publications provide a focused overview of these themes, while the reported citation metrics offer additional context. Verification of complete bibliographic information and individual contributions would strengthen the transparency of an award assessment. [1] [2] [3]

References

  1. Cord blood C-reactive protein and ADHD symptoms at age 5: Evidence from two French birth cohorts. (2026). ScienceDirect. Elsevier.
    https://www.sciencedirect.com/science/article/pii/S0889159126005283
  2. Beyond correlation: Intraclass correlation and Bland–Altman analysis reveal poor absolute agreement across multiplex cytokine immunoassay platforms. (2026). ScienceDirect. Elsevier.
    https://www.sciencedirect.com/science/article/abs/pii/S1043466626001146
  3. Pre-pregnancy body mass index and biomarkers of inflammation at birth. (2026). PubMed. National Library of Medicine.
    https://pubmed.ncbi.nlm.nih.gov/42115734/
  4. Elsevier. (n.d.). Scopus author details: Olfa Khalfallah, Author ID 8641392600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=8641392600

Xuejun Xiao | Bioinformatics | Best Researcher Award

Best Researcher Award

                    Xuejun Xiao
Affiliation Xinjiang Medical University
Country China
Scopus ID 56640335200
Documents 8
Citations 132
h-index 4
Subject Area Bioinformatics
Event Technology Scientists Awards

Xuejun Xiao, Xinjiang Medical University

Xuejun Xiao is affiliated with Xinjiang Medical University, China, and has contributed to bioinformatics and biomedical research through scholarly publications indexed in Scopus. The researcher has authored eight indexed publications, received more than one hundred citations, and demonstrated continued academic engagement in cancer biology, immunology, and nanomedicine research. [1]

Abstract

Xuejun Xiao has contributed to interdisciplinary bioinformatics research with emphasis on cancer biology, immune regulation, molecular therapeutics, and nanoparticle-assisted drug delivery. Published studies investigate immune checkpoint modulation, mechanisms of chemotherapy resistance, and advanced biomedical technologies supporting precision medicine. The available scholarly record demonstrates sustained scientific productivity and measurable citation impact within indexed literature. These achievements indicate meaningful participation in translational biomedical research while supporting future innovation in computational biology, oncology, and therapeutic development through collaborative scientific investigation and evidence-based methodologies. [1] [2] [3]

Keywords

Bioinformatics, Cancer Research, Nanoparticles, Drug Delivery, Gastric Cancer, LUAD, Immunotherapy, Siglec-15, Precision Medicine, Computational Biology.

Introduction

Bioinformatics integrates computational methods with biomedical sciences to improve disease understanding and therapeutic discovery. Xuejun Xiao’s scholarly activities align with this interdisciplinary approach by examining molecular mechanisms associated with cancer progression, immune regulation, and targeted treatment strategies through evidence-based experimental investigations. [1]

Research Profile

The research profile demonstrates experience in oncology, molecular biology, and translational medicine. Indexed publications, citation performance, and collaborative scientific outputs illustrate continued participation in biomedical research focused on identifying clinically relevant biomarkers and innovative therapeutic approaches supporting improved patient outcomes. [2]

Research Contributions

Research contributions include investigations into nanoparticle-mediated antibody delivery, immune checkpoint inhibition, macrophage polarization, and mechanisms responsible for chemotherapy resistance. These studies provide valuable scientific knowledge supporting precision oncology and future therapeutic development through multidisciplinary biomedical research collaborations. [1] [3]

Publications

The Scopus record reports eight indexed publications covering bioinformatics, immunology, cancer biology, and targeted therapeutics. These publications have received academic recognition through citations, reflecting their relevance within contemporary biomedical research and contribution to ongoing scientific discussions in related disciplines. [1]

Research Impact

Citation metrics indicate measurable academic influence, with published research supporting continued investigations into molecular oncology and immunotherapy. The combination of citation performance, interdisciplinary collaborations, and translational relevance highlights the significance of the research within biomedical and bioinformatics communities. [2]

Award Suitability

Based on available scholarly indicators, publication quality, citation record, and sustained contributions to bioinformatics and biomedical sciences, Xuejun Xiao demonstrates qualifications consistent with recognition under the Best Researcher Award for advancing scientific knowledge through impactful and collaborative academic research. [1]

Conclusion

Xuejun Xiao’s academic portfolio reflects meaningful contributions to bioinformatics and cancer research through peer-reviewed publications addressing clinically important biomedical challenges. Continued research activity and scholarly collaboration are expected to further support innovation, translational medicine, and evidence-based healthcare advancement. [1]

External Links

References

  1. Xiao, X., et al. (2026). Application of nanoparticles in antibody drug delivery. Frontiers in Bioengineering and Biotechnology.
    https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2026.1759915/full
  2. Xiao, X., et al. (2022). A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating macrophage polarization in the tumor microenvironment. Cancer Letters.
    https://www.sciencedirect.com/science/article/abs/pii/S1043661822002146
  3. Xiao, X., et al. (2020). PLOD2 increases resistance of gastric cancer cells to 5-fluorouracil by upregulating BCRP and inhibiting apoptosis. Cell Biology International.
    https://pubmed.ncbi.nlm.nih.gov/32284742/
  4. Elsevier. (n.d.). Scopus author details: Xuejun Xiao, Author ID 56640335200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56640335200

Assist. Prof. Dr. Marwa Balaha | Computational Biology | Research Excellence Award

Assist. Prof. Dr. Marwa Balaha | Computational Biology | Research Excellence Award

D’Annunzio University of Chieti–Pescara | Italy

Assist. Prof. Dr. Marwa Balaha, affiliated with the Faculty of Pharmacy in Kafr El-Sheikh, Egypt, is an emerging researcher in the fields of medicinal chemistry, pharmacology, and drug discovery. Her research primarily focuses on the design, synthesis, and biological evaluation of novel therapeutic compounds, particularly targeting metabolic disorders and wound healing applications. With a portfolio of 26 indexed publications, 281 citations and h-index: 11, she demonstrates a consistent contribution to bioactive compound development and translational pharmaceutical research. Her recent work on thiazolidinedione-based dual inhibitors and innovative chromenyl–pyrazolyl derivatives highlights her expertise in multi-target drug design and in vivo validation. Dr. Balaha has established a broad collaborative network, reflected in her extensive co-authorship, facilitating interdisciplinary research across chemistry and biomedical sciences. Her work contributes to addressing global health challenges such as diabetes and tissue regeneration, underscoring its scientific relevance and potential societal impact.

Citation Metrics (Scopus)

281
200
100
10
0

Citations

281

Documents

26

h-index

11

Citations

Documents

h-index


View Scopus Profile
View ORCID Profile
View Google Scholar Profile
View ResearchGate Profile

Top 5 Featured Publications

Vasuk Gautam | Bioinformatics | Best Researcher Award

Dr. Vasuk Gautam | Bioinformatics | Best Researcher Award

Sr.Scientist | Norton Research Institute | United States

Dr. Vasuk Gautam is an emerging researcher whose work spans metabolomics, biomarker discovery, and computational methods for enhancing analytical confidence in high-throughput biological studies. With a record of 24 peer-reviewed publications, 13 h-index and over 3,102 citations, Gautam has established a strong early-career footprint marked by methodological innovation and extensive interdisciplinary collaboration. His contributions focus particularly on developing frameworks for improving metabolite identification accuracy—an essential challenge in metabolomics that directly influences the reliability of biomedical and environmental research. Notably, his recent work introducing the concept of “Identification Probability” provides a transferable, automated metric for evaluating identification confidence, positioning it as a potentially transformative tool for large-scale metabolomic pipelines. In parallel, Gautam has contributed significantly to the development of MarkerDB 2.0, a comprehensive biomarker database that integrates molecular, clinical, and contextual information to support precision medicine, translational research, and global health initiatives. His scholarship reflects a blend of computational rigor, domain expertise, and a commitment to open-access scientific resources. Gautam’s collaborations include partnerships with over 180 co-authors, underscoring his active engagement with diverse research groups and his ability to contribute meaningfully to multi-institutional projects. This collaborative network spans biochemistry, bioinformatics, systems biology, and clinical sciences, highlighting the broad applicability and relevance of his expertise. Through both his methodological contributions and his involvement in global data-resource efforts, Gautam’s work supports reproducibility, accessibility, and evidence-based discovery in molecular life sciences. His growing citation impact and participation in influential open-access initiatives demonstrate both scientific merit and societal relevance, particularly in areas related to disease diagnostics, personalized healthcare, and data-driven research infrastructures.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Wishart, D. S., Guo, A. C., Oler, E., Wang, F., Anjum, A., Peters, H., Dizon, R., … (2022). HMDB 5.0: The human metabolome database for 2022. Nucleic Acids Research, 50(D1), D622–D631.

Cited by: 2116

2. Knox, C., Wilson, M., Klinger, C. M., Franklin, M., Oler, E., Wilson, A., Pon, A., Cox, J., … (2024). DrugBank 6.0: The DrugBank knowledgebase for 2024. Nucleic Acids Research, 52(D1), D1265–D1275.

Cited by: 1112

3. Wishart, D. S., Han, S., Saha, S., Oler, E., Peters, H., Grant, J. R., Stothard, P., … (2023). PHASTEST: Faster than PHASTER, better than PHAST. Nucleic Acids Research, 51(W1), W443–W450.

Cited by: 394

4. Wishart, D. S., Tian, S., Allen, D., Oler, E., Peters, H., Lui, V. W., Gautam, V., … (2022). BioTransformer 3.0: A web server for accurately predicting metabolic transformation products. Nucleic Acids Research, 50(W1), W115–W123.

Cited by: 160

5. Wang, F., Allen, D., Tian, S., Oler, E., Gautam, V., Greiner, R., Metz, T. O., … (2022). CFM-ID 4.0: A web server for accurate MS-based metabolite identification. Nucleic Acids Research, 50(W1), W165–W174.

Cited by: 115

Dr. Vasuk Gautam’s work advances the reliability and scalability of metabolomic and biomarker research, enabling more accurate diagnostics and deeper biological insight. By developing robust identification metrics and contributing to global data resources, he helps accelerate scientific discovery, support precision medicine, and enhance evidence-based decision-making across research, healthcare, and industry.

Béchir Béjaoui | Bioinformatics | Editorial Board Member

Prof. Béchir Béjaoui | Bioinformatics | Editorial Board Member

Researcher | National Institute of Marine Sciences and Technologies | Tunisia

Prof. Béchir Béjaoui is a distinguished marine and environmental scientist affiliated with the National Institute of Marine Sciences and Technologies (INSTM) in Carthage, Tunisia. His research primarily focuses on coastal and marine ecosystem dynamics, climate change impacts, and the application of advanced modeling and machine learning techniques to assess and manage aquatic environments. Over his career, Dr. Béjaoui has authored 34 scientific publications, collectively cited more than 1,130 times across 954 documents, reflecting his strong academic influence and the global relevance of his research. His work integrates remote sensing, numerical modeling, and ecological indicators to evaluate trophic states, water quality, and biodiversity in sensitive environments, such as the Ichkeul Lake Ramsar sanctuary—a UNESCO biosphere reserve and a critical wetland ecosystem in North Africa. Dr. Béjaoui’s studies, including the development of innovative models such as the TRIX-XGBoost Trophic Model and data-driven approaches for forecasting environmental change, provide valuable insights into sustainable wetland management under anthropogenic and climatic pressures. With over 180 international collaborators, his research reflects a strong commitment to multidisciplinary and cross-institutional cooperation, enhancing the global understanding of marine system resilience. His contributions extend beyond academia to inform environmental policy, conservation planning, and adaptive management strategies, bridging the gap between scientific research and socio-environmental decision-making. Through his sustained scholarly output and leadership in marine ecosystem modeling, Dr. Béjaoui continues to play a pivotal role in advancing data-driven sustainability solutions in the Mediterranean and beyond.

Profile: Scopus

Featured Publications

1. Béjaoui, B., … (2025). TRIX-XGBoost Trophic Model for assessing the trophic status of Ichkeul Lake, a Ramsar sanctuary in Northern Tunisia. Marine Pollution Bulletin.

2. Béjaoui, B., … (2025). Remote sensing and numerical modeling to assess the drought in Ichkeul Lake, a RAMSAR wetland and UNESCO biosphere reserve, under climate change. Regional Studies in Marine Science.

3. Béjaoui, B., … (2025, Conference Paper). Machine learning techniques for forecasting the effect of climate change and anthropogenic pressures on coastal wetlands (Ichkeul Lake, Ramsar site).

Prof. Béjaoui’s work drives innovation in environmental modeling, offering scientifically grounded tools to safeguard fragile aquatic ecosystems against climate and human-induced stressors. His research vision promotes sustainable management of marine and wetland resources, contributing to global efforts toward ecological resilience, climate adaptation, and sustainable development.

Daniel Glossman-Mitnik | Computational Biology | Best Academic Researcher Award

Dr. Daniel Glossman-Mitnik | Computational Biology | Best Academic Researcher Award

Emeritus Researcher|Center for Research in Advanced Materials | Mexico

Dr. Daniel Glossman-Mitnik is a prominent researcher at the Centro de Investigación en Materiales Avanzados (CIMAV), Chihuahua, Mexico, recognized internationally for his extensive contributions to computational and theoretical chemistry. His work primarily employs Density Functional Theory (DFT) and Conceptual DFT (CDFT) to investigate the structural, electronic, and reactive properties of molecules and materials relevant to nanotechnology, materials science, and bioactive compounds. With a prolific record of 62 peer-reviewed publications, his research has accumulated over 817 citations, achieving an h-index of 19, which reflects the sustained impact and academic quality of his scientific output. Dr. Glossman-Mitnik’s recent studies encompass a wide spectrum of applications, including the design of triphenylamine-based sensitizers and Cu(I) complexes for dye-sensitized solar cells (DSSCs), as well as computational evaluations of marine natural products and therapeutic peptides for drug discovery. His scholarly endeavors are characterized by interdisciplinary collaboration, having co-authored with more than 120 researchers worldwide, fostering innovation through theoretical–experimental integration. Beyond his methodological expertise, his research has meaningful social and technological implications, contributing to advancements in renewable energy materials, environmentally sustainable chemical design, and computational approaches to pharmacology. By combining rigorous quantum-chemical modeling with practical applications, Dr. Glossman-Mitnik’s work exemplifies how theoretical insights can drive real-world scientific progress. His career reflects a profound commitment to advancing the global understanding of molecular behavior and material performance, positioning him as a leading figure in contemporary computational chemistry.

Profiles: Scopus | Google Scholar

Featured Publications

1. Rodríguez-Valdez, L. M., Villamisar, W., Casales, M., González-Rodríguez, J. G., & others. (2006). Computational simulations of the molecular structure and corrosion properties of amidoethyl, aminoethyl and hydroxyethyl imidazolines inhibitors. Corrosion Science, 48(12), 4053–4064.
Cited by: 248

2. Rodríguez-Valdez, L. M., Martínez-Villafañe, A., & Glossman-Mitnik, D. (2005). Computational simulation of the molecular structure and properties of heterocyclic organic compounds with possible corrosion inhibition properties. Journal of Molecular Structure: THEOCHEM, 713(1), 65–70.
Cited by: 233

3. Glossman-Mitnik, D. (2013). Computational study of the chemical reactivity properties of the Rhodamine B molecule. Procedia Computer Science, 18, 816–825.
Cited by: 131

4. Mendoza-Wilson, A. M., & Glossman-Mitnik, D. (2006). Theoretical study of the molecular properties and chemical reactivity of (+)-catechin and (−)-epicatechin related to their antioxidant ability. Journal of Molecular Structure: THEOCHEM, 761(1), 97–106.
Cited by: 130

5. Gallo, M., Favila, A., & Glossman-Mitnik, D. (2007). DFT studies of functionalized carbon nanotubes and fullerenes as nanovectors for drug delivery of antitubercular compounds. Chemical Physics Letters, 447(1), 105–109.
Cited by: 128

Dr. Daniel Glossman-Mitnik’s work advances global innovation by integrating computational chemistry with materials science and biomedicine, enabling the rational design of sustainable materials and therapeutic compounds. His research bridges theory and application, contributing to cleaner energy technologies, drug discovery, and the broader understanding of molecular behavior for societal and industrial benefit.

Mansoureh Azadeh | Bioinformatics | Women Researcher Award

Dr. Mansoureh Azadeh | Bioinformatics | Women Researcher Award

Lab Manager | Zist Fanavari Novin Biotechnology Institute | Iran

Dr. Mansoureh Azadeh is a distinguished molecular and cellular biologist and the Founder and Director of Zist Fanavari Novin Biotechnology Institute in Isfahan, Iran. With over two decades of leadership in academia, research, and biotechnology entrepreneurship, she has significantly advanced cancer genomics, gene expression analysis, and personalized medicine. Her research spans diverse areas including breast cancer, cardiovascular disease, multiple sclerosis, drug resistance, and athletic genomics. In 2023, she founded PreventiGene, a genetics startup focused on early cancer detection. Dr. Azadeh has served as Chair of the Board at Control Tavan Novin Pouya since 2006, and has also managed the COVID-19 department at Jey Medical Diagnosis Laboratory. An active educator, she has taught for 20 semesters at Azad University and leads national technical training programs in biotechnology. She has authored books on laboratory methods and cancer diagnostics, serves as an editor for medical journals, and regularly collaborates with academic and industry partners to promote scientific innovation. She is widely recognized for her expertise in advanced technologies such as CRISPR, RNA sequencing, and high-throughput data analysis, and has developed and supervised numerous genetic research initiatives. Her technical skills span PCR/qPCR, ELISA, Western blotting, microbiology, and cell culture. As of October 2025, Dr. Azadeh has authored 34 indexed publications, with 313 citations, and holds an h-index of 13 , reflecting her impactful contribution to life sciences and translational research.

Profiles: Scopus | Google Scholar | LinkedIn | ResearchGate

Featured Publications

1. Bagheri, F., Mesrian Tanha, H., Mojtabavi Naeini, M., Ghaedi, K., & Azadeh, M. (2016). Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3′-untranslated region of ErbB4. Molecular Medicine Reports, 13(5), 4494–4498. 
Cited by: 39

2. Ebrahimi Ghahnavieh, L., Tabatabaeian, H., Ebrahimi Ghahnavieh, Z., & others. (2020). Fluctuating expression of miR-584 in primary and high-grade gastric cancer. BMC Cancer, 20, 621. 
Cited by: 31

3. Noormohammad, M., Sadeghi, S., Tabatabaeian, H., Ghaedi, K., Talebi, A., & others. (2016). Upregulation of miR-222 in both Helicobacter pylori-infected and noninfected gastric cancer patients. Journal of Genetics, 95(4), 991–995. 
Cited by: 29

4. Fattahi Dolatabadi, N., Dehghani, A., Shahand, E., Yazdanshenas, M., & others. (2020). The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer. Human Cell, 33(4), 1229–1239.
Cited by: 28

5. Adami, B., Tabatabaeian, H., Ghaedi, K., Talebi, A., Azadeh, M., & Dehdashtian, E. (2019). miR-146a is deregulated in gastric cancer. Journal of Cancer Research and Therapeutics, 15(1), 108–114.
Cited by: 28